{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:20:30Z","timestamp":1788877230972,"version":"build-2803163510"},"reference-count":105,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.npep.2012.07.004","type":"journal-article","created":{"date-parts":[[2012,8,22]],"date-time":"2012-08-22T18:00:16Z","timestamp":1345658416000},"page":"183-193","source":"Crossref","is-referenced-by-count":31,"title":["RETRACTED: Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson\u2019s disease with combined noradrenergic and serotonergic lesions"],"prefix":"10.1016","volume":"46","author":[{"given":"N.","family":"Rampersaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Harkavyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Whitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.S.","family":"Whitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2012.07.004_b0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.jcbfm.9600599","article-title":"Spared caudal brainstem SERT binding in early Parkinson\u2019s disease","volume":"28","author":"Albin","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.npep.2012.07.004_b0010","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1530-0277.1996.tb01102.x","article-title":"Differential age-related loss of pigmented locus coeruleus neurons in suicides, alcoholics, and alcoholic suicides","volume":"20","author":"Arango","year":"1996","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.npep.2012.07.004_b0015","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00702-005-0402-5","article-title":"Influence of noradrenaline denervation on MPTP-induced deficits in mice","volume":"113","author":"Archer","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.npep.2012.07.004_b0020","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jnr.21483","article-title":"Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson\u2019s disease","volume":"86","author":"Bertilsson","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.npep.2012.07.004_b0025","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1471-4159.1992.tb11001.x","article-title":"Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study","volume":"59","author":"Biggs","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2012.07.004_b0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0031-9384(86)90110-1","article-title":"Does the behavioral \u201cdespair\u201d test measure \u201cdespair\u201d?","volume":"38","author":"Borsini","year":"1986","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.npep.2012.07.004_b0035","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbr.2010.05.034","article-title":"Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice","volume":"214","author":"Botton","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2012.07.004_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00229549","article-title":"6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor","volume":"111","author":"Bowenkamp","year":"1996","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.npep.2012.07.004_b0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.npep.2012.07.004_b0050","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/jnr.21642","article-title":"Nonmotor symptoms in Parkinson\u2019s disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model","volume":"86","author":"Branchi","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.npep.2012.07.004_b0055","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/mds.10114","article-title":"Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson\u2019s disease","volume":"17","author":"Burn","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.npep.2012.07.004_b0060","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00125-004-1379-6","article-title":"Glucagon-like peptide-1 prevents beta cell glucolipotoxicity","volume":"47","author":"Buteau","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.npep.2012.07.004_b0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0306-4522(94)00386-J","article-title":"Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus","volume":"64","author":"Castren","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2012.07.004_b0070","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cne.902870308","article-title":"Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson\u2019s disease with and without dementia and depression","volume":"287","author":"Chan-Palay","year":"1989","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2012.07.004_b0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.npep.2012.07.004_b0080","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1124\/mol.107.043968","article-title":"Activation of tyrosine hydroxylase mRNA translation by cAMP in midbrain dopaminergic neurons","volume":"73","author":"Chen","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.npep.2012.07.004_b0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.brainres.2010.11.006","article-title":"Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: time course of protection and neurorestoration","volume":"1370","author":"Cohen","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2012.07.004_b0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0166-4328(01)00211-X","article-title":"Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson\u2019s disease amnesia","volume":"124","author":"da Cunha","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2012.07.004_b0095","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.nlm.2006.12.004","article-title":"Pre-training to find a hidden platform in the Morris water maze can compensate for a deficit to find a cued platform in a rat model of Parkinson\u2019s disease","volume":"87","author":"da Cunha","year":"2007","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.npep.2012.07.004_b0100","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.npep.2012.07.004_b0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnsys.2011.00031","article-title":"Noradrenaline and Parkinson\u2019s disease","volume":"5","author":"Delaville","year":"2011","journal-title":"Front Syst. Neurosci."},{"key":"10.1016\/j.npep.2012.07.004_b0110","doi-asserted-by":"crossref","first-page":"14669","DOI":"10.1073\/pnas.251341998","article-title":"Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease","volume":"98","author":"Du","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.npep.2012.07.004_b0115","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02797.x","article-title":"Tyrosine hydroxylase phosphorylation: regulation and consequences","volume":"91","author":"Dunkley","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2012.07.004_b0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneumeth.2005.04.005","article-title":"Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson\u2019s disease: histological, neurochemical, motor and memory alterations","volume":"148","author":"Ferro","year":"2005","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.npep.2012.07.004_b0125","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrn1195","article-title":"Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS","volume":"4","author":"Filbin","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.npep.2012.07.004_b0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0304-3940(80)90062-2","article-title":"Mesolimbic and mesocortical dopaminergic neurons are necessary for normal exploratory behavior in rats","volume":"17","author":"Fink","year":"1980","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2012.07.004_b0135","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/j.1460-2075.1993.tb05731.x","article-title":"Long-term regulation of serotonergic activity in the rat brain via activation of protein kinase A","volume":"12","author":"Foguet","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.npep.2012.07.004_b0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2999(95)00313-A","article-title":"Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice","volume":"283","author":"Fornai","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2012.07.004_b0145","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein","volume":"102","author":"Fornai","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.npep.2012.07.004_b0150","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.parkreldis.2008.04.038","article-title":"The neuropathological basis for depression in Parkinson\u2019s disease","volume":"15","author":"Frisina","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.npep.2012.07.004_b0155","doi-asserted-by":"crossref","first-page":"10188","DOI":"10.1074\/jbc.M513806200","article-title":"Prolonged activation of cAMP-response element-binding protein and ATF-2 needed for nicotine-triggered elevation of tyrosine hydroxylase gene transcription in PC12 cells","volume":"281","author":"Gueorguiev","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2012.07.004_b0160","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1468-1331.2007.01727.x","article-title":"Brain serotonin transporter binding in non-depressed patients with Parkinson\u2019s disease","volume":"14","author":"Guttman","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.npep.2012.07.004_b0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-2094-5-19","article-title":"Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson\u2019s disease","volume":"5","author":"Harkavyi","year":"2008","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.npep.2012.07.004_b0170","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1476-5381.2009.00486.x","article-title":"Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection","volume":"159","author":"Harkavyi","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2012.07.004_b0175","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.npep.2012.07.004_b0180","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1460-9568.2005.04220.x","article-title":"The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation","volume":"22","author":"Iravani","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.npep.2012.07.004_b0185","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2010.10.008","article-title":"The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test","volume":"650","author":"Isacson","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2012.07.004_b0190","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-0404.2006.00579.x","article-title":"A systematic review of depression and mental illness preceding Parkinson\u2019s disease","volume":"113","author":"Ishihara","year":"2006","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.npep.2012.07.004_b0195","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuint.2010.02.001","article-title":"Induced LC degeneration in APP\/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits","volume":"57","author":"Jardanhazi-Kurutz","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.npep.2012.07.004_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-7091-6360-3_1","article-title":"Post mortem studies in Parkinson\u2019s disease \u2013 is it possible to detect brain areas for specific symptoms?","volume":"56","author":"Jellinger","year":"1999","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.npep.2012.07.004_b0205","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bbr.2009.12.030","article-title":"Tryptophan depletion impairs object-recognition memory in the rat: reversal by risperidone","volume":"208","author":"Jenkins","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2012.07.004_b0210","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/archneur.60.9.1223","article-title":"Positron emission tomography of striatal serotonin transporters in Parkinson disease","volume":"60","author":"Kerenyi","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.npep.2012.07.004_b0215","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1677\/JOE-09-0132","article-title":"Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson\u2019s disease","volume":"202","author":"Kim","year":"2009","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.npep.2012.07.004_b0220","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainres.2010.05.097","article-title":"Desipramine attenuates forced swim test-induced behavioral and neurochemical alterations in mice. an in vivo(1)H-MRS study at 9.4T","volume":"1348","author":"Kim","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2012.07.004_b0225","first-page":"39","article-title":"Biochemistry of Parkinson\u2019s disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson\u2019s disease?","volume":"91","author":"Kish","year":"2003","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.npep.2012.07.004_b0230","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1523\/JNEUROSCI.17-21-08451.1997","article-title":"Reduced levels of norepinephrine transporters in the locus coeruleus in major depression","volume":"17","author":"Klimek","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2012.07.004_b0235","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2005.09.013","article-title":"Central serotonin depletion affects rat brain areas differently: a qualitative and quantitative comparison between different treatment schemes","volume":"392","author":"Kornum","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2012.07.004_b0240","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0006-8993(90)91646-X","article-title":"Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis","volume":"523","author":"Lategan","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2012.07.004_b0245","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.neuro.23.1.155","article-title":"Emotion circuits in the brain","volume":"23","author":"Ledoux","year":"2000","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.npep.2012.07.004_b0250","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-6606-3-8","article-title":"Depression research: where are we now?","volume":"3","author":"Lee","year":"2010","journal-title":"Mol Brain"},{"key":"10.1016\/j.npep.2012.07.004_b0255","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/gps.865","article-title":"SSRIs in the treatment of depression in Parkinson\u2019s disease","volume":"18","author":"Leentjens","year":"2003","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.npep.2012.07.004_b0260","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson\u2019s disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"issue":"Pt 2","key":"10.1016\/j.npep.2012.07.004_b0265","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/brain\/106.2.257","article-title":"Cognitive deficits in the early stages of Parkinson\u2019s disease","volume":"106","author":"Lees","year":"1983","journal-title":"Brain"},{"key":"10.1016\/j.npep.2012.07.004_b0270","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00421543","article-title":"Acute and chronic effects of 4-chloroamphetamine on monoamine metabolism in the rat brain","volume":"46","author":"Leonard","year":"1976","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.npep.2012.07.004_b0275","doi-asserted-by":"crossref","first-page":"e32008","DOI":"10.1371\/journal.pone.0032008","article-title":"Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis","volume":"7","author":"Li","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.npep.2012.07.004_b0280","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1074\/jbc.M209423200","article-title":"Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis","volume":"278","author":"Li","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2012.07.004_b0285","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1471-4159.2010.06731.x","article-title":"Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells","volume":"113","author":"Li","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2012.07.004_b0290","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbr.2003.08.002","article-title":"Acute tryptophan depletion induced by a gelatin-based mixture impairs object memory but not affective behavior and spatial learning in the rat","volume":"151","author":"Lieben","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2012.07.004_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00536.x","article-title":"Depression in Parkinson\u2019s disease \u2013 a review","volume":"113","author":"Lieberman","year":"2006","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.npep.2012.07.004_b0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02252963","article-title":"PET imaging of neocortical monoaminergic terminals in Parkinson\u2019s disease","volume":"9","author":"Marie","year":"1995","journal-title":"J. Neural Transm. Park Dis. Dement. Sect."},{"key":"10.1016\/j.npep.2012.07.004_b0305","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/db08-0799","article-title":"Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington\u2019s disease","volume":"58","author":"Martin","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.npep.2012.07.004_b0310","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0306-4522(91)90345-O","article-title":"Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson\u2019s disease","volume":"41","author":"Mavridis","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2012.07.004_b0315","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/jnp.6.4.428","article-title":"Frontal lobe dysfunction in secondary depression","volume":"6","author":"Mayberg","year":"1994","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.npep.2012.07.004_b0320","first-page":"49","article-title":"Depression in Parkinson\u2019s disease: a biochemical and organic viewpoint","volume":"65","author":"Mayberg","year":"1995","journal-title":"Adv. Neurol."},{"issue":"Suppl.","key":"10.1016\/j.npep.2012.07.004_b0325","first-page":"20","article-title":"Depression in the patient with Parkinson\u2019s disease","volume":"51","author":"Mayeux","year":"1990","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.npep.2012.07.004_b0330","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2012.07.004_b0335","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s11064-010-0133-3","article-title":"Molecular profiling of a 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"35","author":"Na","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.npep.2012.07.004_b0340","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1034\/j.1600-0447.2001.00372.x","article-title":"Increased risk of developing Parkinson\u2019s disease for patients with major affective disorder: a register study","volume":"104","author":"Nilsson","year":"2001","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.npep.2012.07.004_b0345","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0031-9384(88)90266-1","article-title":"Is immobility of rats in the forced swim test \u201cbehavioral despair\u201d?","volume":"42","author":"Nishimura","year":"1988","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.npep.2012.07.004_b0350","doi-asserted-by":"crossref","first-page":"11569","DOI":"10.1073\/pnas.210254597","article-title":"Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons","volume":"97","author":"O\u2019Meara","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.npep.2012.07.004_b0355","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson\u2019s disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.npep.2012.07.004_b0360","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1073858404266776","article-title":"Cognitive dysfunction in Parkinson\u2019s disease: the role of frontostriatal circuitry","volume":"10","author":"Owen","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.npep.2012.07.004_b0365","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.neuro.25.112701.142937","article-title":"Learning and memory functions of the Basal Ganglia","volume":"25","author":"Packard","year":"2002","journal-title":"Annu. Rev. Neurosci."},{"issue":"Suppl 3","key":"10.1016\/j.npep.2012.07.004_b0370","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00415-009-5240-1","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"256","author":"Park","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.npep.2012.07.004_b0375","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1124\/jpet.102.037481","article-title":"Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4","volume":"302","author":"Perry","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2012.07.004_b0380","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1124\/jpet.300.3.958","article-title":"A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells","volume":"300","author":"Perry","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2012.07.004_b0385","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2174\/1389450043345245","article-title":"A new Alzheimer\u2019s disease interventive strategy: GLP-1","volume":"5","author":"Perry","year":"2004","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.npep.2012.07.004_b0390","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1100\/2011\/172893","article-title":"Serotonergic dysfunction in Parkinson\u2019s disease and its relevance to disability","volume":"11","author":"Politis","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.npep.2012.07.004_b0395","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.nbd.2010.05.028","article-title":"Staging of serotonergic dysfunction in Parkinson\u2019s disease: an in vivo 11C-DASB PET study","volume":"40","author":"Politis","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.npep.2012.07.004_b0400","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2012.07.004_b0405","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2006.12.032","article-title":"The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats","volume":"560","author":"Reksidler","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2012.07.004_b0410","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.npep.2012.07.004_b0415","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0006-3223(99)00127-4","article-title":"Role of norepinephrine in the pathophysiology and treatment of mood disorders","volume":"46","author":"Ressler","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.npep.2012.07.004_b0420","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bcp.2007.01.036","article-title":"Norepinephrine: The redheaded stepchild of Parkinson\u2019s disease","volume":"74","author":"Rommelfanger","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.npep.2012.07.004_b0425","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.nlm.2008.06.010","article-title":"Noradrenergic activation of the basolateral amygdala modulates consolidation of object recognition memory","volume":"90","author":"Roozendaal","year":"2008","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.npep.2012.07.004_b0430","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1476-5381.1976.tb08619.x","article-title":"Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart","volume":"58","author":"Ross","year":"1976","journal-title":"Br. J. Pharmacol."},{"issue":"Pt 4","key":"10.1016\/j.npep.2012.07.004_b0435","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/brain\/111.4.941","article-title":"Procedural learning and neostriatal dysfunction in man","volume":"111","author":"Saint-Cyr","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.npep.2012.07.004_b0440","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson\u2019s disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.npep.2012.07.004_b0445","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2012.07.004_b0450","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1038\/npp.2010.114","article-title":"Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models","volume":"35","author":"Schmidt","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2012.07.004_b0455","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/WNL.58.10.1501","article-title":"Increased risk of Parkinson\u2019s disease after depression: a retrospective cohort study","volume":"58","author":"Schuurman","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.npep.2012.07.004_b0460","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1471-4914(03)00117-5","article-title":"Disease model: Parkinson\u2019s disease","volume":"9","author":"Shimohama","year":"2003","journal-title":"Trends Mol. Med."},{"issue":"Suppl. 4","key":"10.1016\/j.npep.2012.07.004_b0465","doi-asserted-by":"crossref","first-page":"IV2","DOI":"10.1007\/s00415-006-4002-6","article-title":"Early diagnosis of Parkinson\u2019s disease","volume":"253","author":"Spiegel","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.npep.2012.07.004_b0470","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1046\/j.1460-9568.2003.02684.x","article-title":"Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats","volume":"17","author":"Srinivasan","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.npep.2012.07.004_b0475","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pbb.2009.12.020","article-title":"MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus","volume":"95","author":"Sy","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2012.07.004_b0480","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","article-title":"Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson\u2019s disease","volume":"156","author":"Tadaiesky","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2012.07.004_b0485","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1523\/JNEUROSCI.1495-09.2009","article-title":"Nonmotor symptoms of Parkinson\u2019s disease revealed in an animal model with reduced monoamine storage capacity","volume":"29","author":"Taylor","year":"2009","journal-title":"J. Neurosci."},{"issue":"Suppl.","key":"10.1016\/j.npep.2012.07.004_b0490","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.parkreldis.2007.06.007","article-title":"The premotor phase of Parkinson\u2019s disease","volume":"13","author":"Tolosa","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.npep.2012.07.004_b0495","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.neuropsychologia.2006.10.007","article-title":"Cortical networks of procedural learning: evidence from cerebellar damage","volume":"45","author":"Torriero","year":"2007","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.npep.2012.07.004_b0500","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brainres.2009.10.070","article-title":"Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson\u2019s disease","volume":"1310","author":"Wang","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2012.07.004_b0505","first-page":"S59","article-title":"Parkinson\u2019s disease\u2013Part 3: Neuropsychiatric symptoms","volume":"14","author":"Weintraub","year":"2008","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.npep.2012.07.004_b0510","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbr.2007.07.002","article-title":"Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats","volume":"184","author":"Winter","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2012.07.004_b0515","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/FBP.0b013e32833aec02","article-title":"Rasagiline improves learning and memory in young healthy rats","volume":"21","author":"Wong","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.npep.2012.07.004_b0520","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1523\/JNEUROSCI.23-07-02939.2003","article-title":"Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites","volume":"23","author":"Yamamoto","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2012.07.004_b0525","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.parkreldis.2006.12.014","article-title":"Non-motor dysfunction in Parkinson\u2019s disease","volume":"13","author":"Ziemssen","year":"2007","journal-title":"Parkinsonism Relat. Disord."}],"updated-by":[{"DOI":"10.1016\/j.npep.2013.04.004","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"record-id":"2901"}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417912000716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417912000716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T16:19:37Z","timestamp":1714321177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417912000716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":105,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0143417912000716"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2012.07.004","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}